Search by Drug Name or NDC
NDC 69238-1420-09 Silodosin 8 mg/1 Details
Silodosin 8 mg/1
Silodosin is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is SILODOSIN.
MedlinePlus Drug Summary
Silodosin is used in men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia; BPH), which include difficulty urinating (hesitation, dribbling, weak stream, and incomplete bladder emptying), painful urination, and urinary frequency and urgency. Silodosin is in a class of medications called alpha-blockers. It relieves the symptoms of BPH by relaxing the muscles of the bladder and prostate.
Related Packages: 69238-1420-09Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Silodosin
Product Information
| NDC | 69238-1420 |
|---|---|
| Product ID | 69238-1420_2ae50691-7fd9-4a62-894c-535faada8041 |
| Associated GPIs | 56852060000140 |
| GCN Sequence Number | 064847 |
| GCN Sequence Number Description | silodosin CAPSULE 8 MG ORAL |
| HIC3 | Q9B |
| HIC3 Description | BENIGN PROSTATIC HYPERTROPHY/MICTURITION AGENTS |
| GCN | 16858 |
| HICL Sequence Number | 036119 |
| HICL Sequence Number Description | SILODOSIN |
| Brand/Generic | Generic |
| Proprietary Name | Silodosin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Silodosin |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/1 |
| Substance Name | SILODOSIN |
| Labeler Name | Amneal Pharmaceuticals NY LLC |
| Pharmaceutical Class | Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209745 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 69238-1420-09 (69238142009)
| NDC Package Code | 69238-1420-9 |
|---|---|
| Billing NDC | 69238142009 |
| Package | 90 CAPSULE in 1 BOTTLE (69238-1420-9) |
| Marketing Start Date | 2018-12-03 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.62403 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | SILODOSIN 8 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis